Used as a key chiral intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting central nervous system disorders. Its structural features make it valuable in developing serotonin and norepinephrine reuptake inhibitors. The compound’s stereochemistry enhances selectivity and potency in drug candidates, especially in antidepressants and anxiolytic agents. It is also employed in the preparation of novel kinase inhibitors and receptor modulators due to its favorable binding properties with target proteins. Its fluorinated aromatic ring improves metabolic stability and bioavailability in final drug formulations.